Tag: biologics
State-of-the-art evidence and novel developments in biologics for spine fusion
The opening symposium at the 2019 Global Spine Congress (15–18 May, Toronto, Canada) focused on cutting edge updates in spine surgery. Scott Boden addressed...
SpinalCyte granted new Japanese patent
SpinalCyte, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, has been issued a new...
ChoiceSpine launches biologics portfolio
ChoiceSpine has launched a new biologics portfolio at its National Sales Meeting in Nashville, USA.
The Biologics product portfolio is marketed under two brands named...
ChoiceSpine appoints Christy Cote as vice president of Biologics
ChoiceSpine has announced the appointment of Christy Cote as vice president of Biologics. According to a company release, she is a business leader with...
Bone Therapeutics reports positive efficacy data for Allob phase 2A spinal...
Bone Therapeutics has reported positive efficacy data for its phase IIA spinal fusion trial with Allob. Results of the first half of patients in...